EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial DNA competition: starving out the mutant genome

Antonella Spinazzola, Diego Perez-Rodriguez, Jan Ježek, Ian J Holt

Trends in Pharmacological Sciences · 2024-03 · 45 (3) · 225-242

DOI: 10.1016/j.tips.2024.01.011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2024-03. Verfasst von Antonella Spinazzola und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Royal Free Campus, London NW3 2PF, UK. Electronic address…. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Mitochondria. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Brain Research UK, CIBERNED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High levels of pathogenic mitochondrial DNA (mtDNA) variants lead to severe genetic diseases, and the accumulation of such mutants may also contribute to common disorders. Thus, selecting against these mutants is a major goal in mitochondrial medicine. Although mutant mtDNA can drift randomly, mounting evidence indicates that active forces play a role in the selection for and against mtDNA variants. The underlying mechanisms are beginning to be clarified, and recent studies suggest that metabolic cues, including fuel availability, contribute to shaping mtDNA heteroplasmy. In the context of pathological mtDNAs, remodeling of nutrient metabolism supports mitochondria with deleterious mtDNAs and enables them to outcompete functional variants owing to a replicative advantage. The elevated nutrient requirement represents a mutant Achilles' heel because small molecules that restrict nutrient consumption or interfere with nutrient sensing can purge cells of deleterious mtDNAs and restore mitochondrial respiration. These advances herald the dawn of a new era of small-molecule therapies to counteract pathological mtDNAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, MitochondrialMitochondriaHumans

Stichwörter der Autor:innen

2-Deoxy-d-glucoseepigenetic rewiringheteroplasmymitochondrial DNAnutrient metabolismnutrient signaling

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Royal Free Campus, London NW3 2PF, UK. Electronic address: a.spinazzola@ucl.ac.uk.
  • Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Royal Free Campus, London NW3 2PF, UK.
  • Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Royal Free Campus, London NW3 2PF, UK; Biodonostia Health Research Institute, 20014 San Sebastián, Spain; IKERBASQUE (Basque Fo…

Förderung

  • Medical Research Council
  • Brain Research UK
  • CIBERNED
  • The Champ Foundation
  • Carlos III Health Institute
  • Universidad del Pais Vasco
  • The Lily Foundation
  • UKRI Medical Research Council

Zitieren

APA

Spinazzola, A., Perez-Rodriguez, D., Ježek, J., & Holt, I. J. (2024). Mitochondrial DNA competition: starving out the mutant genome. Trends in Pharmacological Sciences, 45(3), 225-242. https://doi.org/10.1016/j.tips.2024.01.011

Vancouver

Spinazzola A, Perez-Rodriguez D, Ježek J, Holt IJ. Mitochondrial DNA competition: starving out the mutant genome. Trends in Pharmacological Sciences. 2024;45(3):225-242. doi:10.1016/j.tips.2024.01.011

BibTeX
@article{Spinazzola2024,
  author = {Spinazzola, Antonella and Perez-Rodriguez, Diego and Ježek, Jan and Holt, Ian J},
  title = {Mitochondrial DNA competition: starving out the mutant genome},
  journal = {Trends in Pharmacological Sciences},
  year = {2024},
  volume = {45},
  number = {3},
  pages = {225--242},
  doi = {10.1016/j.tips.2024.01.011}
}
Kostenlos starten →